drugset / Trial / NCT03766217

Bone Tissue Engineering With Dental Pulp Stem Cells for Alveolar Cleft Repair

NCT03766217 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

Iliac crest autogenous bone graft is accepted as the most effective method for secondary alveolar cleft repair. However this method is associated with complications. As an alternative, mesenchymal stem cells associated with biomaterials have been used for the rehabilitation of the alveolar bone cleft of patients with cleft lip and palate. This is a RCT comparing mesenchymal stem cells obtained from autogenous deciduous dental pulp associated with biomaterials versus iliac crest autogenous bone graft for secondary alveolar cleft repair.

Timeline

Start
2019-04-05
Primary completion
2019-12-06
Completion
2019-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Deciduous dental pulp mesenchymal stem cells Unknown — —

Indications